The current status of new antidiabetic drugs

Sudhakar Pemminati, Richard Mark Millis, Ashwin Kamath, Ashok Kudgi Shenoy, Vasavi Rakesh Gorantla

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)291-292
Number of pages2
JournalJournal of Pharmacopuncture
Volume19
Issue number4
DOIs
Publication statusPublished - 01-12-2016

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Complementary and alternative medicine

Cite this

Pemminati, Sudhakar ; Millis, Richard Mark ; Kamath, Ashwin ; Shenoy, Ashok Kudgi ; Gorantla, Vasavi Rakesh. / The current status of new antidiabetic drugs. In: Journal of Pharmacopuncture. 2016 ; Vol. 19, No. 4. pp. 291-292.
@article{97bee51866e54369b63b588068ddccf2,
title = "The current status of new antidiabetic drugs",
author = "Sudhakar Pemminati and Millis, {Richard Mark} and Ashwin Kamath and Shenoy, {Ashok Kudgi} and Gorantla, {Vasavi Rakesh}",
year = "2016",
month = "12",
day = "1",
doi = "10.3831/KPI.2016.19.029",
language = "English",
volume = "19",
pages = "291--292",
journal = "Journal of Pharmacopuncture",
issn = "2093-6966",
publisher = "Korean Pharmacopuncture Institute",
number = "4",

}

The current status of new antidiabetic drugs. / Pemminati, Sudhakar; Millis, Richard Mark; Kamath, Ashwin; Shenoy, Ashok Kudgi; Gorantla, Vasavi Rakesh.

In: Journal of Pharmacopuncture, Vol. 19, No. 4, 01.12.2016, p. 291-292.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The current status of new antidiabetic drugs

AU - Pemminati, Sudhakar

AU - Millis, Richard Mark

AU - Kamath, Ashwin

AU - Shenoy, Ashok Kudgi

AU - Gorantla, Vasavi Rakesh

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=85019963627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019963627&partnerID=8YFLogxK

U2 - 10.3831/KPI.2016.19.029

DO - 10.3831/KPI.2016.19.029

M3 - Article

VL - 19

SP - 291

EP - 292

JO - Journal of Pharmacopuncture

JF - Journal of Pharmacopuncture

SN - 2093-6966

IS - 4

ER -